LINCOLN PHARMACEUTICALS
Back to Balance Sheet
|
LINCOLN PHARMACEUTICALS Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹3.12 Cr | ₹0.23 Cr | ₹0.23 Cr | ₹0.23 Cr | ₹1.46 Cr |
What is the latest Contingent Liabilities ratio of LINCOLN PHARMACEUTICALS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹3.12 Cr |
| Mar2024 | ₹0.23 Cr |
| Mar2023 | ₹0.23 Cr |
| Mar2022 | ₹0.23 Cr |
| Mar2021 | ₹1.46 Cr |
How is Contingent Liabilities of LINCOLN PHARMACEUTICALS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹3.12 Cr | 1,250.65 | |
| Mar2024 | ₹0.23 Cr | 0.00 | |
| Mar2023 | ₹0.23 Cr | 0.00 | |
| Mar2022 | ₹0.23 Cr | -84.22 | |
| Mar2021 | ₹1.46 Cr | - | |
Compare Contingent Liabilities of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹1,158.0 Cr | -3.6% | -6.1% | 7.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,179.0 Cr | -0.4% | 4.3% | 13.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,095.0 Cr | 0.9% | 8.9% | 8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,530.0 Cr | 0.7% | 13% | 46.5% | Stock Analytics | |
| CIPLA | ₹114,318.0 Cr | -1% | -0% | -3.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,742.1 Cr | -3.3% | -8.4% | -4.3% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | -3.6% |
-6.1% |
7.8% |
| SENSEX | -0.6% |
-0.1% |
-6.7% |
You may also like the below Video Courses